Edit |   |
---|---|
Antigenic Specificity | CCL2, Human (Carlumab biosimilar) |
Clone | Carlumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CCL2 Recombinant Antibody. Carlumab (alternate identifier CNTO 888) is a discontinued human recombinant monoclonal antibody (type IgG1 kappa) that targets human CC chemokine ligand 2 (CCL2)/monocyte chemoattractant protein (MCP1). Carlumab was under development for use in the treatment of oncology and immune indications and was studied for application in systemic sclerosis, atherosclerosis, diabetic nephropathy, liver fibrosis and type 2 diabetes. |
Immunogen | n/a |
Other Names | Anti-CCL2 Recombinant Antibody, Research Grade Carlumab, Anti-Human CCL2 Recombinant Antibody, CNTO 888, Antibody Drug Analogues, Monoclonal Antibody, YR1239, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 915404-94-3 |
Catalog # | YR1239 |
Price | please inquire |
Order / More Info | CCL2, Human (Carlumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |